Literature DB >> 27664261

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F Lordick1, C Mariette2, K Haustermans3, R Obermannová4, D Arnold5.   

Abstract

Entities:  

Year:  2016        PMID： 27664261     DOI： 10.1093/annonc/mdw329

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  240 in total

Review 1.  Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed?

Authors:  Costanza Chiapponi; Felix Berlth; Patrick S Plum; Christopher Betzler; Dirk L Stippel; Felix Popp; Christiane J Bruns
Journal:  Visc Med       Date:  2017-02-15

2.  The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.

Authors:  Toru Aoyama; Yosuke Atsumi; Shinnosuke Kawahara; Hiroshi Tamagawa; Ayako Tamagawa; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Masakatsu Numata; Takashi Oshima; Norio Yukawa; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC).

Authors:  Adedayo A Onitilo; Trista J Stankowski-Drengler; Oyewale Shiyanbola; Jessica Engel; Sabo Tanimu; Seth O Fagbemi; Ya-Huei Li
Journal:  Clin Med Res       Date:  2021-03-31

4.  Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.

Authors:  Wing-Keen Yap; Yu-Chuan Chang; Chia-Hsun Hsieh; Yin-Kai Chao; Chien-Cheng Chen; Ming-Chieh Shih; Tsung-Min Hung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-30       Impact factor: 9.236

5.  Open surgical treatment for esophageal cancer: transhiatal vs. transthoracic, does it really matter?

Authors:  Uriel Clemente-Gutiérrez; Heriberto Medina-Franco; Oscar Santes; Jesús Morales-Maza; Alejandro Alfaro-Goldaracena; Martin J Heslin
Journal:  J Gastrointest Oncol       Date:  2019-08

Review 6.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

Review 7.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

Review 8.  [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].

Authors:  I Gockel; F Lordick; O Lyros; N Kreuser; A H Hölscher; C Wittekind
Journal:  Chirurg       Date:  2020-01       Impact factor: 0.955

9.  Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Sandro Barni; Giovanni Sgroi; Rodolfo Passalacqua; Gianluca Tomasello
Journal:  Gastric Cancer       Date:  2018-11-27       Impact factor: 7.370

10.  Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients.

Authors:  Stefania Martini; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Viviana Contu; Christian Fiandra; Riccardo Ragona; Giorgia Catalano; Maria Antonietta Satolli; Michele Camandona; Renato Romagnoli; Umberto Ricardi; Pierfrancesco Franco
Journal:  Med Oncol       Date:  2018-10-04       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.